OTX-TKI (Axpaxli) offers a novel approach for wet macular degeneration with sustained drug release up to 9 months via a hydrogel platform. Two phase 3 trials, SOL-1 and SOL-R, evaluate Axpaxli's ...
Google’s new Computer Control feature could enable automated control of Android apps similar to the Rabbit R1. Here’s how.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback